From: Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement
Adalimumab
Placebo
Appendicitis1,4
Gastritis2,4
Tendonitis2,4
Sequence Adalimumab-Adalimumab
Sequence Placebo- Adalimumab
Pain2,4
Colitis3,4
Vertigo3,4
Pyelonephritis1,4